• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Artikel
  4. Association of human FOS promoter variants with the occurrence of knee-osteoarthritis in a case control association study
 
  • Details
  • Full
Options
2019
Journal Article
Title

Association of human FOS promoter variants with the occurrence of knee-osteoarthritis in a case control association study

Abstract
Our aim was to analyse (i) the presence of single nucleotide polymorphisms (SNPs) in the JUN and FOS core promoters in patients with rheumatoid arthritis (RA), knee-osteoarthritis (OA), and normal controls (NC); (ii) their functional influence on JUN/FOS transcription levels; and (iii) their associations with the occurrence of RA or knee-OA. JUN and FOS promoter SNPs were identified in an initial screening population using the Non-Isotopic RNase Cleavage Assay (NIRCA); their functional influence was analysed using reporter gene assays. Genotyping was done in RA (n = 298), knee-OA (n = 277), and NC (n = 484) samples. For replication, significant associations were validated in a Finnish cohort (OA: n = 72, NC: n = 548). Initially, two SNPs were detected in the JUN promoter and two additional SNPs in the FOS promoter in perfect linkage disequilibrium (LD). JUN promoter SNP rs4647009 caused significant downregulation of reporter gene expression, whereas reporter gene expression was significantly upregulated in the presence of the FOS promoter SNPs. The homozygous genotype of FOS promoter SNPs showed an association with the susceptibility for knee-OA (odds ratio (OR) 2.12, 95% confidence interval (CI) 1.2-3.7, p = 0.0086). This association was successfully replicated in the Finnish Health 2000 study cohort (allelic OR 1.72, 95% CI 1.2-2.5, p = 0.006). FOS Promoter variants may represent relevant susceptibility markers for knee-OA.
Author(s)
Huber, René
Waldkliniken Eisenberg
Kirsten, Holger
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Näkki, Annu
Universität Helsinki
Pohlers, Dirk
Waldkliniken Eisenberg
Thude, Hansjörg
Universitätsklinikum Jena
Eidner, Thorsten
Universitätsklinikum Jena
Heinig, Matthias
Max-Planck-Institut für molekulare Genetik, Berlin
Brand, Korbinian
Medizinische Hochschule Hannover (MHH)
Ahnert, Peter
Universität Leipzig
Kinne, Raimund W.
Waldkliniken Eisenberg
Journal
International journal of molecular sciences  
Open Access
DOI
10.3390/ijms20061382
Additional full text version
Landing Page
Language
English
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024